Prävention und Therapie der Osteoporose mit Mikronährstoffen

Zusammenfassung

Eine gute Versorgung mit Vitaminen, Mineralien, Spurenelementen und anderen Mikronährstoffen ist zur Prävention und Therapie der Osteoporose essenziell. Die Praxisübersicht erläutert, welche Mikronährstoffe für die Osteoporoseprävention und -therapie besonders wichtig sind und welche Dosierungen infrage kommen.

Abstract

A good supply with vitamins, minerals, trace elements and other micronutrients is essential for the prevention and therapy of osteoporosis. The practice-oriented overview explains, which micronutrients are especially important for the prevention and therapy of osteoporosis, and which dosages are possible.

Schlüsselwörter

Osteoporose - orthomolekulare Medizin - Mikronährstoffe

Keywords

Osteoporosis - orthomolecular medicine - micronutrients

Literatur

• 01 Dachverband Osteologie e. V. . DVO-Leitlinie 2009 zur Prophylaxe, Diagnostik und Therapie der Osteoporose bei Erwachsenen.  Osteologie. 2009;  4 304-324
• 02 Hang J. Antioxidant intake and risk of osteoporotic hip fracture in Utah: An effect modified by smoking status.  Am J Epidemiol. 2006;  163 9-17
• 03 Tucker K L et al.. Effects of beer, wine, and liquor intakes on bone mineral density in older men and women.  Am J Clin Nutr. 2009;  89 1188-1196
• 04 Berg K M et al.. Association between alcohol consumption and both osteoporotic fracture and bone density.  Am J Med. 2008;  121 406-418
• 05 Mukamal K J et al.. Alcohol consumption, bone density, and hip fracture among older adults: the cardiovascular health study.  Osteoporos Int. 2007;  18 593-602
• 06 Cawthon P M et al.. Alcohol intake and its relationship with bone mineral density, falls, and fracture risk in older men.  J Am Geriatr Soc. 2006;  54 1649-1657
• 07 Ginaldi L et al.. Osteoporosis, inflammation and ageing.  Immun Ageing. 2005;  2 14
• 08 Roggia C et al.. Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency.  Minerva Med. 2004;  95 125-132
• 09 Roggia C et al.. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo.  Proc Natl Acad Sci. 2001;  98 13960-13965
• 10 Sanchez-Rodriguez M et al.. Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes.  BMC Musculoskelet Disord. 2007;  8 124
• 11 Grassi F et al.. Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation.  Proc Natl Acad Sci. 2007;  104 15087-15092
• 12 Ries H et al.. Der Orthopäde.  2001;  30 451-455
• 13 Haney E M et al.. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.  Arch Intern Med. 2007;  167 1246-1251
• 14 Cauley J A et al.. Factors associated with the lumbar spine and proximal femur bone mineral density in older men.  Osteoporos Int. 2005;  16 1526-1537
• 15 Feldkamp J. Long-term anticonvulsant therapy leads to low bone mineral density – evidence for direct drug effects of phenytoin and carbamazepin on human osteblast-like cells.  Exp Clin Endocrinol Diabetes. 2000;  108 37-43
• 16 Pedrera J D et al.. Influence of vitamin D administration on bone ultrasound measurements in patients on anticonvulsant therapy.  Eur J Clin Invest. 2000;  30 895-899
• 17 McLean R R et al.. Homocysteine a a predicive factor for hip fracture in older persons.  N Engl J Med. 2004;  350 2042-2049
• 18 Van Meurs J B J et al.. Homocysteine levels and the risk of osteoporotic fracture.  N Engl J Med. 2004;  350 2033-2041
• 19 Bucciarelli P et al.. The relationship between plasma homocysteine levels and bone mineral density in post-menopausal women.  Eur J Intern Med. 2010;  21 301-305
• 20 Gjesdal C G et al.. Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study.  Arch Intern Med. 2006;  166 88-94
• 21 Das G et al.. Hypovitaminosis D among healthy adolescent girls attending an inner city school.  Archives of Disease in Childhood. 2006;  91 569-572
• 22 Blinkley N et al.. Low vitamin D status depite abundant sun exposure.  J Clin Endocrinol Metab. 2007;  92 2130-2135
• 23 Bischoff-Ferrari H A et al.. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes.  American Journal of Clinical Nutrition. 2006;  84 18-28
• 24 Steingrimsdottir L et al.. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake.  JAMA. 2005;  294 2336-2341
• 25 Di Daniele N et al.. Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double-blind, randomized, controlled trial.  Pharmacol Res. 2004;  50 (6) 637-641
• 26 Chapuy M C et al.. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyreoidism and hip fracture: The Decalyos II Study.  Osteoporos Int. 2002;  13 257-264
• 27 Boonen et al.. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials.  J Clin Endocrinol Metab. 2007;  92 (4) 1415-1423
• 28 Hall S L et al.. Postmenopausal estrogen/progestin interventions trial; the relation of dietary vitamin C intake to bone mineral density: results from the PEPI study.  Calcif Tissue Int. 1998;  63 (3) 183-189
• 29 Morton D J. 29. Treffen der American Society of Bone and Mineral Research, San Diego.  ÄZ. 1997; 
• 30 Sahni S et al.. Protective effect of total and supplemental vitamin C intake on the risk of hip fracture – a 17-year follow-up from the Framingham Osteoporosis Study.  Osteoporos Int. 2009;  20 1853-1856
• 31 Booth S L et al.. Vitamin K intake and bone mineral density in women and men.  Am J Clin Nutr. 2003;  77 512-516
• 32 Knapen M H et al.. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women.  Osteoporosis Int. 2007;  18 963-972
• 33 Yoshihiro Sato et al.. Effect of folate and mecobalamin on hip fractures in patients with stroke. A randomized controlled trial.  JAMA. 2005;  293 1082-1088
• 34 Cagnacci A et al.. Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women.  Bone. 2003;  33 (6) 956-959
• 35 Hahar D et al.. Nutritional status in relation to balance and falls in the elderly. A prelaminary look at serum folate.  Ann Nutr Metab. 2009;  6 59-66
• 36 Tucker K L et al.. Low plasma vitamin B12 is associated with lower BMD: the Framingham Osteoporosis Study.  J Bone Miner Res. 2005;  20 152-158
• 37 Ilich J Z et al.. Bone and nutrition in elderly women: protein, energy, and calcium as main determinants of bone mineral density.  Eur J Clin Nutr. 2003;  57 (4) 554-565
• 38 Alekel D L et al.. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women.  Am J Clin Nutr. 2000;  72 844-852
• 39 Ye Y B et al.. Soy isoflavones attenuate bone loss in early positmenopausal chinese women: a single-blind randomized, placebo-controlled trial.  Eur J Nutr. 2006;  45 327-334
• 40 Marini H et al.. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women.  Annals of International Medicine. 2007;  146 839-847
• 41 Ho S C et al.. Soy protein consumption and bone mass in early postmenopausal Chinese women.  Osteoporos Int. 2003;  14 835-842
• 42 Wong W W et al.. Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial.  Am J Clin Nutr. 2009;  90 1433-1439
• 43 Sahni S et al.. Inverse association of carotenoid intakes with 4-y change in bone mineral density in elderly men and women: the Framingham Osteoporosis Study.  Am J Clin Nutr. 2009;  89 416-424
• 44 Mackinnon E S et al.. Supplementation with the antioxidant lycopene significantly decreases oxidative stress parameters and the bone resorption marker N-telopeptide of type I collagen in postmenopausal women.  Osteoporos Int. 2010;  22 (4) 1091-1101
• 45 Sahni S et al.. Protective effect of total carotenoid and lycopene intake on the risk of hip fracture: a 17-year follow-up from the Framingham Osteoporosis Study.  J Bone Miner Res. 2009;  24 1086-1094
• 46 Arjmandi et al.. Dried plums improve indices of bone formation in postmenopausal women.  J Women's Health Gend Based Med. 2002;  11 61-68
• 47 Chih-Hsing Wu et al.. Epidemiological Evidence of Increased Bone Mineral Density in Habitual Tea Drinkers.  Arch Intern Med. 2002;  162 1001-1006
• 48 Sellmeyer D E et al.. A high ratio of dietary animal to vegetable protein increases the rate of bone loss and the risk of frature in postmenopausal women.  Am J Clin Nutr. 2001;  73 118-122
• 49 Torricelli P et al.. Human osteopenic bone-derived osteoblasts: essential amino acids treatment effects.  Artificial Cells, Blood Substitutes, and Biotechnology. 2003;  31 35-46
• 50 Visser J J et al.. Arginine supplementation in the prevention and treatment of osteoporosis.  Med Hypotheses. 1994;  43 339-342
• 51 Civitelli R et al.. Dietary l-lysine and calcium metabolism in humans.  Nutrition. 1992;  8 400-405
• 52 Chevalley T et al.. Arginine increases insulin-like growth factor-I production and collagen synthesis in osteoblast-like cells.  Bone. 1998;  23 (2) 103-109
• 53 Marangella M al.. Effects of potassium citrate supplementation on bone metabolism.  Calcif Tissue Int. 2004;  74 330-335
• 54 New S A et al.. Dietary influence on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health.  American Journal of Clinical Nutrition. 2000;  71 142-151
• 55 Anad C. Effect of protein intake on calcium balance of young men given 500 mg calcium daily.  Journal of Nutrition. 1974;  104 695
• 56 Hegsted M. Urinary calcium and calcium balance in young men as affected by protein and phosphorous intake.  Journal of Nutrition. 1981;  111 53
• 57 Allen L et al.. Protein-induced hypercalcuria: a longer-term study.  American Journal of Clinical Nutrition. 1979;  32 741
• 58 Jajoo R et al.. Dietary acid-base balance, bone resorption, and kalzium excretion.  J Am Coll Nutr. 2006;  25 224-230
• 59 McGartland C P et al.. Fruit and vegetable consumption and bone mineral density: the Northern Ireland Young Hearts Project.  Am J Clin Nutr. 2004;  80 1019-1023
• 60 Feskanich D et al.. Protein consumption and bone fractures in women.  Am J Epidemiol. 1996;  143 472-479
• 61 Bawa S. The significance of soy protein and soy bioactive compounds in the prophylaxis and treatment of osteoporosis.  Osteoporos. 2010;  2010 891058
• 62 Wachman A, Bernstein D S. Diet and osteoporosis.  Lancet. 1968;  4 958-959
• 63 Leman J et al.. The effects of chronic acid loads in normal men: further evidence for the participation of bone mineral in the defence against chronic metabolic acidosis.  Journal of Clinical Investigation. 1966;  43 1608-1614
• 64 Buhsinsky D A et al.. Chronic acidosis-induced alteration in bone bicarbonate and phosphate.  Am J Physiol Renal Physiol. 2003;  285 F532-539
• 65 Bushinsky D A et al.. Acute acidosis-induced alteration in bone bicarbonate and phosphate.  Am J Physiol Renal Physiol. 2002;  283 F1091-1097
• 66 Bushinsky D A. Acidosis and bone.  Miner Electrolyte Metab. 1994;  20 40-52
• 67 Krieger N S et al.. Cellular mechanisms of bone resorption induced by metabolic acidosis.  Semin Dial. 2003;  16 463-466
• 68 Bushinsky D A. Acid-base imbalance and the skeleton.  Eur J Nutr. 2001;  40 238-244
• 69 Arnett T. Regulation of bone cell function by acid-base balance.  Proc Nutr Soc. 2003;  62 511-520
• 70 Brandao-Burch A et al.. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization.  Calcif Tissue Int. 2005;  77 167-174
• 71 Arnett T R. Extracellular pH regulates bone cell function.  J Nutr. 2008;  138 415S-418S
• 72 Feskanich D et al.. Vitamin K intake and hip fractures in women: a prospective study.  American Journal of Clinical Nutrition. 1999;  69 74-79
• 73 Binkley N D, Suttie J W. Vitamin K nutrition and osteoporosis.  Journal of Nutrition. 1995;  125 1812-1821
• 74 Schaafsma A et al.. Vitamin D3 and Vitamin K1 supplementation of dutch postmenopasal women with normal and low bone mineral densities: effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin.  European Journal of Clinical Nutrition. 2000;  54 626-631
• 75 Dawson-Hughes B et al.. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women.  Annals of Internal Medicine. 1991;  115 505-512
• 76 Dawson-Hughes B et al.. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.  N Engl J Med. 2001;  337 670-676
• 77 Abraham G E. The importance of magnesium in the management of primary osteoporosis.  Journal of Nutritional and Environmental Medicine. 1991;  2 165-178
• 78 EatonEvans J et al.. Copper supplementation and the maintenance of bone mineral density in middle-aged women.  The Journal of Trace Elements in Experimental Medicine. 1996;  9 87-94
• 79 Relea P et al.. Zinc, biochemical markers of nutrition, and type I osteoporosis.  Age and Aging. 1995;  24 303-307
• 80 Strause L et al.. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals.  J Nutr. 1994;  124 1060-1064
• 81 Saltman P D, Strause L G. The role of trace minerals in osteoporosis.  J Am Coll Nutr. 1993;  12 384-389
• 82 Nielson F H et al.. Effect of dietary boron on mineral, estrogen and testosterone metabolism in postmenopausal women.  FASB J. 1987;  1 394-397
• 83 Newnham R E. Essentiality of boron for healthy bones and joints.  Environ Health Perspect. 1994;  102 83
• 84 Nielsen F H et al.. Boron enhances and mimics some effects of estrogen therapy in postmenopausal women.  J Trace Elem Exp Med. 1992;  58 237
• 85 Meacham S L et al.. Effects of boron supplementation on bone mineral density and dietary, blood, and urinary calcium, phosphorus, magnesium, and boron in female athletes.  Environ Health Perspect. 1994;  102 Suppl 7 79-82
• 86 Zhang J. Antioxidant intake and risk of osteoporotic hip fracture in Utah: an effect modified by smoking status.  Am J Epidemiol. 2006;  163 9-17
• 87 Wezemann F H et al.. Vitamin D and ibandronate prevent cancellous bone loss associated with binge alcohol treatment in male rats.  Bone. 2007;  41 639-645
• 88 Siffledeen J S et al.. Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn's disease.  Clin Gastroenterol Hepatol. 2005;  3 (2) 122-132
• 89 Homic J et al.. Calcium and vitamin D for corticosteroid-induced osteoporosis.  The Cochrane Library. Issue 3, 2004; 
• 90 Gallagher J C et al.. ÄZ.  2002; 
• 91 Broe K E et al.. A higher dose of Vitamin D reduces the risk of falls in nursering homeresidents: a randomized, multipledose study.  J Am Geriatr Soc.  2007;  55 234-239
• 92 Chapuy M C et al.. Vitamin D3 and calcium to prevent hip fractures in the elderly women.  N Engl J Med. 1992;  327 1637-1642
• 93 Sato Y et al.. Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease.  Bone. 2005;  36 61-68
• 94 Reginster J Y et al.. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study.  The Journal of Clinical Endocrinology & Metabolism. 2005;  90 (5) 2816-2822
• 95 Meunier P J. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis (SOTI).  N Engl J Med. 2004;  350 (5) 459-468
• 96 Michaelsson K et al.. Serum retinol levels and the risk of fracture.  N Engl J Med. 2003;  348 287-294
• 97 Melhus H, Michaelsson K, Kindmark A et al.. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture.  Ann Intern Med. 1998;  129 770-778
• 98 Feskanich D et al.. Vitamin A intake and hip fractures among postmenopausal women.  JAMA. 2002;  287 47-54

Korrespondenzadresse